The risk for azathioprine -induced myelosuppression in the patients with the heterozygous TPMT * 1 / * 3C genotype was significantly higher than that in patients with the wild-type genotype ( adjusted OR , 14.18 [ 95 % CI , 3.07-65 .40 ] ; P < 0.005 ) .